Skip to search formSkip to main contentSkip to account menu

de novo myelodysplastic syndromes

Known as: de novo Myelodysplastic Syndrome, untreated myelodysplastic syndromes, myelodysplastic syndromes, de novo 
A primary myelodysplastic syndrome not associated with prior radiation or chemotherapy treatment.
National Institutes of Health

Related topics

Related topics

7 relations
Bone MarrowBone marrow stem cellHematopoietic and Lymphoid CellHematopoietic and Lymphoid Tissue

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Association of A313G glutathione S-transferase P1 germline polymorphism with susceptibility to de novo myelodysplastic syndrome
Abstract Models for the pathogenesis of myelodysplastic syndrome (MDS) imply the role of individual genetic variations in genes… 
2012
2012
Aberration of p73 promoter methylation in de novo myelodysplastic syndrome
Abstract p73, a tumor suppressor gene with significant homology to p53, is hypermethylated in a high percentage of NK-cell… 
2004
2004
Absence of MLL gene rearrangement in de novo myelodysplastic syndromes (MDS)
The Mixed Lineage Leukemia (MLL) gene has been identified in 11q23 translocations. The aim of the present study is the… 
2001
2001
Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems
Abstract. A number of prognostic scoring systems for patients with myelodysplastic syndromes (MDS) have been introduced in the… 
2001
2001
Spontaneous remission in adult patients with de novo myelodysplastic syndrome: a possible event.
BACKGROUND AND OBJECTIVES Spontaneous remission (SR) in de novo myelodysplastic syndromes (MDS) is a rare event, which has been… 
Highly Cited
2000
Highly Cited
2000
Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome
Gene amplification is one of the mechanisms for activating proto‐oncogenes resulting in an enhanced expression of the… 
1997
1997
The 17p-syndrome: a distinct myelodysplastic syndrome entity?
The 17p- syndrome is a subset of myelodysplastic syndrome characterized by "typical" dysgranulopoïesis, combining a pseudo-Pelger… 
1996
1996
Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de Moelle.
We report on 71 consecutive patients with de novo myelodysplastic syndromes referred to physicians belonging to the Société fran… 
1993
1993
Myelodysplastic syndrome with eosinophilia in bone marrow
Summary. Clinical features were investigated in 114 patients with de novo myelodysplastic syndrome (MDS) diagnosed over the past… 
Highly Cited
1992
Highly Cited
1992
Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)